1. Home
  2. GKOS vs GBTG Comparison

GKOS vs GBTG Comparison

Compare GKOS & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • GBTG
  • Stock Information
  • Founded
  • GKOS 1998
  • GBTG 2014
  • Country
  • GKOS United States
  • GBTG United States
  • Employees
  • GKOS N/A
  • GBTG N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • GBTG Computer Software: Prepackaged Software
  • Sector
  • GKOS Health Care
  • GBTG Technology
  • Exchange
  • GKOS Nasdaq
  • GBTG Nasdaq
  • Market Cap
  • GKOS 5.4B
  • GBTG 4.3B
  • IPO Year
  • GKOS 2015
  • GBTG N/A
  • Fundamental
  • Price
  • GKOS $84.11
  • GBTG $7.84
  • Analyst Decision
  • GKOS Strong Buy
  • GBTG Strong Buy
  • Analyst Count
  • GKOS 13
  • GBTG 4
  • Target Price
  • GKOS $121.46
  • GBTG $9.88
  • AVG Volume (30 Days)
  • GKOS 864.7K
  • GBTG 874.2K
  • Earning Date
  • GKOS 11-03-2025
  • GBTG 11-04-2025
  • Dividend Yield
  • GKOS N/A
  • GBTG N/A
  • EPS Growth
  • GKOS N/A
  • GBTG N/A
  • EPS
  • GKOS N/A
  • GBTG N/A
  • Revenue
  • GKOS $432,953,000.00
  • GBTG $2,440,000,000.00
  • Revenue This Year
  • GKOS $28.90
  • GBTG $4.83
  • Revenue Next Year
  • GKOS $25.57
  • GBTG $4.84
  • P/E Ratio
  • GKOS N/A
  • GBTG N/A
  • Revenue Growth
  • GKOS 26.70
  • GBTG 3.61
  • 52 Week Low
  • GKOS $77.10
  • GBTG $5.78
  • 52 Week High
  • GKOS $163.71
  • GBTG $9.60
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.81
  • GBTG 44.20
  • Support Level
  • GKOS $79.02
  • GBTG $7.88
  • Resistance Level
  • GKOS $89.29
  • GBTG $8.24
  • Average True Range (ATR)
  • GKOS 3.19
  • GBTG 0.20
  • MACD
  • GKOS 0.54
  • GBTG -0.07
  • Stochastic Oscillator
  • GKOS 49.76
  • GBTG 0.00

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

Share on Social Networks: